Arkolith/Insider Trading/LYEL/Form 4

Ramachandra Sumant

DirectorLyell Immunopharma, Inc. (LYEL) · full profile →Form 4 · filed Mar 25, 2025
Net Buying
Open-Market Buys
$116K
Open-Market Sells
$0
Net Open-Market Flow
$116K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 21, 2025Buy(P)200K$0.58$116K200K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-008942) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML